The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wiley Matthew T. since 2019.
This trader's CIK number is 1759703.
At the time of last reporting, Wiley Matthew T. was the Chief Commercial Officer of Bioxcel Therapeutics, Inc.. (stock ticker symbol BTAI).
Also see all insider trading activities at Bioxcel Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | FOMX | 13,440 | $50,534 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BTAI | 0 | $0 | 7,739 | $6,561 | 4,500 | $0 |
1. Foamix Pharmaceuticals Ltd. (FOMX)
2. Bioxcel Therapeutics, Inc. (BTAI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-05 | FOMX | Buy | 13,440 | 3.76 | 50,534 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-03 | BTAI | Sale | 6,272 | .55 | 3,449 |
| 2024-09-16 | BTAI | Sale | 215 | .69 | 148 |
| 2024-09-15 | BTAI | Option Ex | 750 | .00 | 0 |
| 2024-06-17 | BTAI | Sale | 244 | 1.26 | 308 |
| 2024-06-15 | BTAI | Option Ex | 750 | .00 | 0 |
| 2024-04-04 | BTAI | Sale | 1,008 | 2.63 | 2,656 |
| 2024-03-15 | BTAI | Option Ex | 3,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wiley Matthew T. (Chief Commercial Officer of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.